Wang Ren, Patel Dhruvesh, Goruk Susan, Richard Caroline, Field Catherine J
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
J Nutr. 2024 Dec;154(12):3790-3802. doi: 10.1016/j.tjnut.2024.10.021. Epub 2024 Oct 12.
Suckling and weaning arachidonic acid (ARA) + docosahexaenoic acid (DHA) supplementation promoted oral tolerance (OT) development in pups, however, the effect of it on the intestine to promote OT development remains unknown.
We aimed to explore the impact of this supplementation on intestinal fatty acid composition, structure, and indicators that are supportive of OT development.
Allergy-prone Brown Norway dams were randomly assigned to a control (0% ARA, 0% DHA) or ARA + DHA diet (0.45% ARA, 0.8% DHA) during suckling (0-3 wk). At weaning (3-8 wk), offspring were randomly assigned to a control (0% ARA, 0% DHA) or ARA + DHA diet (0.5% ARA, 0.5% DHA). At 3 wk, offspring in each group received an oral gavage of sucrose or ovalbumin (OVA) solution for five consecutive days. At 7 wk, all offspring received an intraperitoneal OVA injection. At 8 wk, offspring were terminated to evaluate jejunum morphology and measure mucosal food allergy-related secretory immunoglobulin A (sIgA) and cytokines, ileum phospholipid and triglyceride fatty acid compositions, and fecal calprotectin.
Weaning ARA + DHA resulted in a higher percentage of DHA in ileum phospholipids and triglycerides (both P < 0.001), without affecting the percentage of ARA. Despite no lasting effect of suckling ARA + DHA on the DHA content in ileum phospholipids, a programming effect was found on the allergy-related intestinal immune profile [higher concentrations of mucosal IL-2 (P = 0.049) and sIgA (P = 0.033)]. OVA treatment resulted in a lower concentration of mucosal IL-6 (P = 0.026) regardless of dietary interventions. Offspring fed ARA + DHA during suckling and/or weaning had a higher concentration of mucosal transforming growth factor-beta (TGF-β) after OVA treatment but this was not observed in offspring fed control diets during suckling and weaning (P = 0.04).
Early life dietary ARA + DHA supplementation to allergy-prone rats enhanced the DHA concentration in intestinal phospholipids (weaning period) and increased the mucosal sIgA, IL-2, and TGF-β levels (suckling and weaning period), indicating its ability to create a tolerogenic intestinal environment to support OT development.
哺乳期和断奶期补充花生四烯酸(ARA)+二十二碳六烯酸(DHA)可促进幼崽口服耐受(OT)的发展,然而,其对肠道促进OT发展的作用尚不清楚。
我们旨在探讨这种补充剂对肠道脂肪酸组成、结构以及支持OT发展的指标的影响。
将易过敏的棕色挪威母鼠在哺乳期(0-3周)随机分为对照组(0% ARA,0% DHA)或ARA+DHA饮食组(0.45% ARA,0.8% DHA)。在断奶期(3-8周),将后代随机分为对照组(0% ARA,0% DHA)或ARA+DHA饮食组(0.5% ARA,0.5% DHA)。在3周时,每组后代连续5天接受蔗糖或卵清蛋白(OVA)溶液的灌胃。在7周时,所有后代接受OVA腹腔注射。在8周时,处死后代以评估空肠形态,并测量黏膜食物过敏相关的分泌型免疫球蛋白A(sIgA)和细胞因子、回肠磷脂和甘油三酯脂肪酸组成以及粪便钙卫蛋白。
断奶期补充ARA+DHA可使回肠磷脂和甘油三酯中的DHA百分比更高(均P<0.001),而不影响ARA的百分比。尽管哺乳期补充ARA+DHA对回肠磷脂中DHA含量没有持久影响,但发现对过敏相关的肠道免疫谱有编程效应[黏膜IL-2(P=0.049)和sIgA(P=0.033)浓度更高]。无论饮食干预如何,OVA处理均导致黏膜IL-6浓度降低(P=0.026)。在哺乳期和/或断奶期喂食ARA+DHA的后代在OVA处理后黏膜转化生长因子-β(TGF-β)浓度更高,但在哺乳期和断奶期喂食对照饮食的后代中未观察到这种情况(P=0.04)。
对易过敏大鼠进行生命早期饮食ARA+DHA补充可提高肠道磷脂中DHA浓度(断奶期),并增加黏膜sIgA、IL-2和TGF-β水平(哺乳期和断奶期),表明其有能力创造一个促耐受的肠道环境以支持OT发展。